Company Overview
Haoxi Health Technology Limited operates within the Communication Services sector, specifically functioning as an Advertising Agency that provides online marketing solutions in China. The company executes its business model through a network of subsidiaries that deliver online short video marketing solutions to advertisers via media partners, alongside customized marketing solutions that involve planning, producing, and placing content. This entity currently maintains a market capitalization of $65.98M and employs 26 individuals to support its operational activities. The reported annual revenue of $32.80M combined with a market cap of $65.98M indicates a valuation that exceeds the company's trailing twelve-month revenue by more than double, suggesting a market premium or specific investor expectations regarding future growth potential that are not immediately reflected in current sales figures.
Financial Health
The company reported a revenue of $32.80M and a net income of $3.88M for the trailing twelve months, while its EBITDA stands at -$1,705,292. The significant gap between the positive net income of $3.88M and the negative EBITDA of -$1,705,292 reveals a cost structure where interest expenses and non-operating costs are substantial enough to transform a profitable operating entity into one with negative earnings before interest, taxes, depreciation, and amortization. Furthermore, the free cash flow is reported at -$6,025,760, which indicates that the company is currently burning cash rather than generating liquidity from its operations, thereby limiting its immediate financial flexibility for capital expenditures or unplanned opportunities without external financing. When analyzing profitability margins, the gross margin is 2.8%, the operating margin is -21.2%, and the profit margin is 11.8%; the negative operating margin suggests that operating expenses are exceeding gross profit, yet the positive profit margin implies that non-operating income or other gains are sufficient to turn the final net income positive. Regarding balance sheet leverage, the company holds $8.62M in cash against $2.02M in debt, resulting in a debt-to-equity ratio of 11.63, which presents a complex picture where high cash reserves offset significant debt obligations relative to equity, yet the leverage ratio remains elevated. The current ratio is 5.05, indicating a highly conservative short-term liquidity position where current assets are five times greater than current liabilities, ensuring the ability to meet short-term obligations easily. Finally, the return on equity is 27.1% while the return on assets is -6.7%, revealing that management is generating strong returns on the shareholders' capital but is destroying value relative to the total asset base, likely due to the negative EBITDA and high interest costs associated with the debt load.
Valuation Assessment
The trailing P/E ratio is 0.84, while the forward P/E is listed as N/A, implying that analysts do not have a consensus on future earnings growth or that the projected earnings are insufficient to calculate a meaningful forward multiple based on current expectations. The price-to-book ratio is 0.19, indicating that the stock is trading at less than one-fifth of its book value, which suggests the market values the company's assets at a significant discount compared to the accounting value recorded on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 2.01 and an EV/EBITDA of 1.98 provide additional context; the P/S ratio of 2.01 suggests investors are willing to pay roughly twice the revenue to acquire a share, while the EV/EBITDA of 1.98 reflects a low enterprise value relative to earnings before interest, taxes, depreciation, and amortization, despite the negative EBITDA figure. The 52-week high is $2.31 and the 52-week low is $0.82, placing the current trading environment within a range that has seen significant volatility over the past year. The beta is -0.46, which indicates that the stock price moves inversely to the broader market with less than half the volatility of the market, suggesting a unique risk profile distinct from standard market correlations.
Growth & Income
The revenue growth year-over-year is -64.6%, whereas the earnings growth year-over-year is 172.7%, demonstrating that earnings are growing significantly faster than revenue, a phenomenon often seen when companies with high fixed costs or significant non-operating income experience a decline in sales but maintain or improve profitability through cost adjustments or one-time gains. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the entity retains all of its net income for reinvestment or to bolster its cash reserves rather than distributing cash to shareholders. This retention strategy is consistent with the company's negative free cash flow, as it prioritizes maintaining liquidity over returning capital to investors. Overall, the growth and income profile is characterized by a decoupling of top-line sales decline from bottom-line profit expansion, with no current income distribution to shareholders.